GlassScriptPhysician profile
Douglas E Holt
NPI 1417310046
$3,510.57
in general payments reported to CMS, 2019-2025
46 companies · $1,244 in 2025
The $1,244 reported for 2025 was more than what 86% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $32.30 · 2021: $298 · 2022: $472 · 2023: $629 · 2024: $834 · 2025: $1,244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,707.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $351.39 | 2022-2025 | Enhertu, Datroway |
| Astrazeneca Pharmaceuticals LP | $320.95 | 2021-2025 | Imfinzi, Lynparza, Calquence |
| Janssen Biotech, INC. | $250.04 | 2022-2025 | Erleada, Akeega, Balversa |
| Merck Sharp & Dohme LLC | $248.89 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Genentech USA, INC. | $181.85 | 2022-2025 | Venclexta, Tecentriq, Phesgo |
| Alexion Pharmaceuticals, INC. | $144.53 | 2021-2025 | Ultomiris |
| Eisai INC. | $117.35 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $110.65 | 2023-2025 | |
| Novocure INC. | $107.90 | 2024-2025 | Optune, Optune Gio, Optune Lua (Novottf-200t) |
| Medtronic, INC. | $103.22 | 2022-2024 | Synchromedii, Osteocool Rf Ablation System |
| Takeda Pharmaceuticals U.S.A., INC. | $102.75 | 2024-2025 | Fruzaqla, Iclusig, Ninlaro |
| Elekta, INC. | $98.30 | 2021 | |
| Sumitomo Pharma America, INC. | $96.60 | 2024-2025 | Orgovyx |
| Lilly USA, LLC | $87.10 | 2023-2025 | Jaypirca, Verzenio |
| Pfizer INC. | $82.02 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Holt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.